The company specializes in middle market, lower mid-market, and small cap buyout investments across advanced industrials, automation, energy transition, business services, healthcare, and other diversified sectors. Innovation in fund offerings and strategic partnerships drive diversification while strong demand for alternatives and mid-market expertise position Bridgepoint for robust earnings and investor appeal.
Cyborg Score Rationale
Overall consensus analyst recommendation is Buy, with analyst consensus target price at 382.88p, representing 46% upside. However, the stock has declined 27% over the past year, reflecting recent market headwinds.
Top Insights
Private Equity generates maximum revenue among reporting segments (Private Equity, Credit, Infrastructure, and Central), providing diversified income streams
Company operates with 513 employees as of Feb 2026, maintaining lean operational structure
Dividend yield of 3.56% with £0.09 annual dividend provides shareholder returns
EBITDA of £298.1M with 48.56% margin demonstrates operational efficiency
Named Competitors
Private Equity and Credit Management — Diversified alternative asset manager with global reach
Private Equity Platform — Global investment firm with mid-market focus
Alternative Asset Management — Leading private equity and infrastructure investor
Recent Developments
(Feb 2026) Issued 30 million new shares as ECP sellers convert units
(Feb 2026) Confirmed admission of new shares and updated voting rights
(Feb 2026) Cancelled newly repurchased shares in ongoing buyback programme
(Mar 2026) Earnings report scheduled for March 12, 2026
Open the full interactive Bridgepoint Group plc report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.